Clinical Trials Sponsored by Beata Krasinska
Total 285 results
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompletedAdvanced Solid Tumors | Lymphoid MalignanciesUnited States
-
Reata, a wholly owned subsidiary of BiogenTerminatedPancreatic Neoplasms | Pancreatic CancerUnited States
-
Reata, a wholly owned subsidiary of BiogenNo longer available
-
Universidad Francisco de VitoriaUniversidad Rey Juan Carlos; Hospital Beata María AnaNot yet recruitingPain | Parkinson DiseaseSpain
-
Universidad Francisco de VitoriaUniversidad Rey Juan Carlos; Hospital Beata María AnaCompletedPain | Parkinson DiseaseSpain
-
Istituto Auxologico ItalianoIRCCS Istituto Neurologico Carlo BestaRecruitingMultiple Sclerosis | Healthy | Parkinson Disease | Healthy Aging | Peripheral Neuropathy | Rare DiseasesItaly
-
Reata, a wholly owned subsidiary of BiogenTerminatedChronic Kidney Diseases | Autosomal Dominant Polycystic Kidney | Alport SyndromeUnited States, France, Australia, Japan, Spain, Puerto Rico
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetic NephropathyUnited States
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy VolunteersUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, ChronicUnited States
-
Betta Pharmaceuticals Co., Ltd.Tigermed Consulting Co., LtdTerminatedMild to Moderate PsoriasisChina
-
Uppsala University HospitalBeta-O2 Technologies Ltd.Active, not recruiting
-
Reata, a wholly owned subsidiary of BiogenRecruitingA Phase 2 Study of RTA 901 in Patients With Diabetic Peripheral Neuropathic Pain (CYPRESS) (CYPRESS)Diabetic Peripheral Neuropathic PainUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy VolunteersUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompletedHepatic ImpairmentUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenWithdrawnDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenTerminatedLiver DiseaseUnited States
-
Reata, a wholly owned subsidiary of BiogenTerminatedDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenWithdrawnDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy | Hepatic ImpairmentUnited States
-
Betta Pharmaceuticals Co., Ltd.Tigermed Consulting Co., LtdCompleted
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompleted
-
Reata, a wholly owned subsidiary of BiogenCovanceCompletedHealthy Adult SubjectsUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedMetastatic or Incurable Non-small Cell Lung Cancer | Relapsed, Refractory MelanomaUnited States
-
Li PengBetta Pharmaceuticals Co., Ltd.CompletedNeurofibromatosis Type 2 | Vestibular SchwannomaChina
-
Peking University Cancer Hospital & InstituteBetta Pharmaceuticals Co., Ltd.UnknownEGFR Positive Non-Small Cell Lung Cancer,AdenocarcinomaChina
-
University of FloridaBeat Childhood Cancer Research ConsortiumRecruitingNeuroblastoma | Diffuse Intrinsic Pontine GliomaUnited States
-
Zealand PharmaMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1United States
-
Massachusetts General HospitalZealand Pharma; Beta Bionics, Inc.Completed
-
Peking Union Medical College HospitalBetta Pharmaceuticals Co., Ltd.RecruitingCarcinoma, Non-Small-Cell Lung | Anaplastic Lymphoma Kinase I1171N | EnsartinibChina
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedOcular Inflammation | Ocular Pain | Corneal Endothelial Cell Loss | Cataract SurgeryUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedInflammation and Pain Following Ocular SurgeryUnited States
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompletedMItochondrial MyopathiesUnited States, Denmark
-
Reata, a wholly owned subsidiary of BiogenAbbVieCompleted
-
Beijing Mabworks Biotech Co., Ltd.Betta Pharmaceuticals Co., Ltd.CompletedNon-small Cell Lung CancerChina
-
Universidad Francisco de VitoriaUniversidad Nacional de Educación a Distancia; Hospital Beata María AnaNot yet recruitingCerebral Palsy | Paediatric Stroke | Paediatric Brain Damage | Paediatric Traumatic Brain Injury | Paediatric Acquired Brain InjurySpain
-
Fondazione Don Carlo Gnocchi OnlusCarlo Besta Neurological InstituteRecruitingDisorder of ConsciousnessItaly
-
Peking University Cancer Hospital & InstituteBetta Pharmaceuticals Co., Ltd.RecruitingNSCLC Stage IV | NSCLC Stage IIIB | ALK PositiveChina
-
Beat GöpfertInnosuisse - Swiss Innovation AgencyRecruitingGait, Drop FootSwitzerland
-
The University of Hong KongBeat Drugs Fund AssociationCompletedCognitive Dysfunction | Substance Use | Cocaine Use | Methamphetamine Abuse | Stimulant UseHong Kong
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...University of Milano BicoccaCompletedMigraine Disorders | Medication Overuse Headache